Location
Remote, United States of America
Job Type
Full-time  
Remote
Remote

Description

AD, HEOR – Rare Disease | Pharma |Remote based – Profitable, commercial stage, smaller pharma | reports to Head of HEOR – RETAINED SEARCH

Cornerstone Search Group’s HEOR/Market Access/RWE/Data Science practice has been retained by a profitable, commercial-stage, and publicly-traded rare disease pharma for a newly-created and remote-based Associate Director, Health Economics & Outcomes Research position. This role reports to a personable and highly-skilled Head of HEOR, whom we previously helped our client hire. We know first-hand about this company’s positive work culture from working with them to hire multiple professionals as they have grown. This is a proverbial “Best of Both Worlds” opportunity to join a smaller company and work closely with senior management help define the future while at the same time enjoying the stability of working for a publicly-traded, profitable, and commercial stage pharmaceutical company.

In this role, you will bring leadership to the execution of HEOR strategies to support evidence-based decision-making, market access, and product value demonstration. You will be responsible for developing and executing robust HEOR, RWE and Epi plans that are aligned with medical affairs strategies, clinical development plans, and commercial strategies to support product value propositions and to optimize market access. You will actively participate on cross-functional teams (US and ex-US) and need to demonstrate strong scientific leadership and strategic thinking that is both patient-centric and commercially oriented.

Features

4 HIGHLY ATTRACTIVE FEATURES:

(1) Gain Rare / Ultra-Rare Disease Experience: A great opportunity to gain coveted rare and ultra-rare disease experience for a company that has launched both rare and ultra-rare disease drugs. Our client is comfortable hiring an individual that would like to gain rare disease experience as they are more focused on the individual’s HEOR/business/communication skills, IQ, and EQ.

(2) Remote Work Arrangement: This company has had remote-working arrangements prior to COVID and the hiring manager, who is the Head of HEOR, also works remotely.

(3) Strong Culture: We have partnered with this client previously and have been impressed by their leadership stability (which is very unusual in this day and age) and the collaborative culture they have forged, which has been greatly enjoyed by the people we have helped them hire. They have done an exemplary job of building a management team comprised of team-first, high EQ leaders who are passionate about working in the rare disease sector and enjoy working with each other.

(4) This is a “rare” rare-disease small pharma that has multiple approved drugs, is publicly traded, and is profitable  Unlike many small pharmas which are pre-commercial stage, our client enjoys the stability that comes from having already launched multiple drugs, is profitable, and is publicly-traded.

Responsibilities

SCOPE OF RESPONSIBILITIES:

 Strategic Input:  

  • Provide strategic direction for HEOR initiatives in alignment with company goals.
  • Critically assess the drivers of, and barriers to, reimbursement and market access, and provide input into clinical, regulatory, payer/access, marketing and evidence generation strategy and programs.
  • Develop strategies to demonstrate the unmet need with a focus on outcomes that are meaningful to patients, payers, clinical decision-makers, and regulators.
  • Provide strategic input into clinical trial design, emphasizing the incorporation of relevant health economic and PRO measures.

Deliverables:

  • Plan and manage RWE and economic evidence activities for both in-line and pipeline products to meet the value evidence needs of health systems, clinicians, payers, HTA/reimbursement agencies, and policymakers.
  • Ensure that evidence generation activities are conducted with appropriate scientific rigor and are strategically aligned with cross-functional teams in clin dev, med affairs, market access, reg affairs, etc.
  • Lead clinical outcome assessment initiatives for clinical trial programs.
  • Manage multiple HEOR projects, associated budgets, and external and internal partnerships.
  • Continue to educate yourself on new scientific and methodological developments within HEOR and the company’s therapeutic areas.
  • Oversee the development of publications, posters, and presentations.
  • Work with Med Affairs, Market Access, and Marketing to package HEOR evidence for field materials.

 DESIRED SKILLS, EXPERIENCES & QUALIFICATIONS:

  • MS/MPH, PharmD, or PhD with training in a relevant discipline (e.g., economics, epi, health services research, public health, etc.)
  • 2+ years of relevant experience (HEOR or RWE or Epi) in a pharma/biotech or consulting company conducting HEOR / RWE/ Epi work for pharma/biotech. Our client may consider someone for a Director title if their relevant experience warrants such consideration.
  • Our client is open to different therapeutic areas of experience. Rare disease experience is only a plus.
  • COA / PRO experience is a plus.
  • Understanding of both the US and global market access and reimbursement landscape is a plus.
  • Seeking a proactive and enthusiastic leader who can manage multiple priorities simultaneously.
  • Seeking someone who is passionate about helping patients in the rare disease and ultra rare disease communities they focus on.

Contact

Corey Ackerman
Corey S. Ackerman, JD Email: cackerman@cornerstonesg.com Phone: 973-656-0220x716 LinkedIn: http://www.linkedin.com/in/coreyackerman
Cornerstone Search Group, LLC
350 Main Street | Chatham, New Jersey 07928, USA
www.cornerstonesg.com

Recently Completed Retained Searches by Cornerstone

REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS:
  • CEO | specialty pharma start-up
  • CEO | regenerative medicine start-up
  • CEO | CRO start-up
  • CFO | public oncology biotech
  • US CEO | established European small pharma
  • CFO | public US oncology biotech
  • President/US Commercial Head | generics pharma
  • CMO | mid-size pharma
  • CMO | late-stage public biotech
  • CMO | early-stage Boston oncology public biotech
  • CSO | mid-size global biotech
  • SVP, Head of Global Medical Affairs | mid-size oncology company
  • SVP, Head of Global Clinical Development | multi-TA mid-size pharma
  • SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
  • VP, Global Commercial Head | API Business Unit | Indian pharma
  • VP, Data Science RWE | Top 5 Pharma
  • VP, Head of Regulatory Affairs | Boston biotech
  • VP, US Head of Regulatory Affairs | Top 20 Pharma
  • VP, Head of R&D Operations | Boston biotech
  • VP, Head of US HEOR & RWE | Top 5 Pharma
  • VP, Head of Real-World Evidence | Top 5 pharma
  • VP, Head of Global Market Access | Top Oncology Specialty Pharma
  • VP, Head of US Market Access | West Coast Late-Stage Public Biotech
  • VP, Head of Heme/Onc Clinical Research | Public oncology biotech
  • VP, Head of Clinical Development | late-stage anti-infectives UK pharma
  • VP, Head of Global Drug Safety & PV | Chinese oncology biotech
  • Head, Patient Advocacy | European commercial-stage rare disease biotech

Cornerstone's Privacy Policy

Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.

Apply for AD, HEOR – Rare Disease
Drop files here browse files ...
Back To Featured Searches List
Are you sure you want to delete this file?
/